Toxicities associated with checkpoint inhibitor immunotherapy
Authors
Michael Postow, MD
Assistant Attending Physician
Memorial Sloan-Kettering Cancer Center
Assistant Professor of Medicine
Weill Medical College of Cornell University
Jedd Wolchok, MD, PhD
Chief
Melanoma and Therapeutics Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Medical College of Cornell University
Section Editor
Michael B Atkins, MD
Section Editor — Malignant Melanoma and Other Cutaneous Neoplasms; Cancer of the Kidney
Deputy Director
Georgetown Lombardi Comprehensive Cancer Center
Deputy Editor
Michael E Ross, MD
Senior Deputy Editor — UpToDate
Deputy Editor — Oncology
Peer Reviewer
Reviewers are not identified on topic reviews to preserve anonymity